Repository for the Family Investigation of Nephropathy & Diabetes
Repository for the Family Investigation of Nephropathy & Diabetes
批准号:
10043394
负责人:
LEONARD FREEDMAND
金额:
$4.12万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-31 至 2020-08-30
关键词:
AffectCell LineChargeChronicCryopreserved CellDatabasesDiabetes MellitusDiabetic NephropathyDiseaseENG geneEnd stage renal failureFamilyGenesGenetic Predisposition to DiseaseGoalsHyperglycemiaHypertensionIndividualInstitutionInsulin-Dependent Diabetes MellitusInterventionInvestigationKidney DiseasesLinkNational Institute of Diabetes and Digestive and Kidney DiseasesNon-Insulin-Dependent Diabetes MellitusPatientsPhenotypePlasmaPredispositionPrognostic FactorResearch PersonnelSamplingSecureUrinegenetic technologypreservationrepositorysample collection
中文摘要
糖尿病肾病(DN)是一种多因素疾病,并且大部分受1型或2型糖尿病影响的患者发展为糖尿病肾病并进展为终末期肾病(ESRD)。当预后不良的因素如高血压和慢性高血糖得到积极治疗时,糖尿病肾病的进展速度可以减缓。然而,没有任何干预措施能可靠地阻止糖尿病肾病的进展。许多研究表明,糖尿病肾病的遗传易感性存在,但肾病的基因尚未分离。预计对大量的统一表型的ESRD家族进行综合分析将是分离ESRD基因所必需的。任何一个机构都可能没有这样的家庭数据库。FIND联盟的任务是获得具有良好特征的糖尿病肾病的家庭和个人的集合,建立安全的主FIND数据库,并使用遗传技术来识别与糖尿病肾病相关的染色体区域,以识别糖尿病肾病易感性或保护基因。在FIND期间收集的样本的储存库对于FIND研究实现其目标以及对这一宝贵样本收集的后续研究至关重要。
英文摘要
Diabetic nephropathy (DN) is a multifactoral disease, and a large proportion of patients affected with either type 1 or type 2 diabetes develop diabetic nephropathy and progress to end stage renal disease (ESRD). When poor prognostic factors such as hypertension and chronic hyperglycemia are aggressively treated, the rate of progression of diabetic nephropathy can be slowed. However, no interventions have been shown to reliably halt the progression of diabetic nephropathy. Numerous studies have suggested that genetic predisposition to diabetic nephropathy exists, but genes for nephropathy have not yet been isolated. It is anticipated that a comprehensive analysis of a large number of uniformly phenotyped ESRD families will be necessary to isolated genes for ESRD. Such a database of families may not be available at any single institution. The charge of the FIND consortium was to acquire sets of families and individuals with well-characterized diabetic nephropathy, establish a secure master FIND database, and use genetic technologies to identify chromosomal regions linked with diabetic nephropathy in order to identify diabetic nephropathy susceptibility or protection genes. A Repository of samples collected during the FIND is essential for the FIND study to achieve its goals and for subsequent studies of this valuable sample collection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DCP - Cancer Prevention Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia) BioRepository
-
批准号:10199869
-
项目类别:
-
资助金额:$3.99万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
TAS::75 0849::TAS INCREMENTAL FUNDING
-
批准号:10038552
-
项目类别:
-
资助金额:$4.87万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
Strategic Scientific Pilot Support
-
批准号:10040640
-
项目类别:
-
资助金额:$168.64万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
Informatics Support at FNLCR
-
批准号:10040668
-
项目类别:
-
资助金额:$3581.76万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
DCP- Cancer Immunoprevention Laboratory Support
-
批准号:10043975
-
项目类别:
-
资助金额:$215.48万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
DCEG- GWAS Studies
-
批准号:10038401
-
项目类别:
-
资助金额:$715.44万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
DCP - COPTRG Support [National Surgical Adjuvant Breast and Bowel Project (NSABP)
-
批准号:10199862
-
项目类别:
-
资助金额:$3.99万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
Eye Exams Associated with Anetumab Ravtansine Administration
-
批准号:10038614
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
Biospecimen Collection Proteomic
-
批准号:10040642
-
项目类别:
-
资助金额:$548.12万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
TCGA CLinical Data Update
-
批准号:10043657
-
项目类别:
-
资助金额:$140.65万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
DCEG- Repository Services for epidemiology studies
-
批准号:10038403
-
项目类别:
-
资助金额:$231.33万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
ETCTN Biorepository Specimens to the University of Ottawa
-
批准号:10038619
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
RAS Program at FNL
-
批准号:10040657
-
项目类别:
-
资助金额:$908.0万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
DCP Support- HPV16L1/RG1 Virus-Like Particle Vaccine
-
批准号:10043970
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
HPV Serology
-
批准号:10040624
-
项目类别:
-
资助金额:$87.43万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
Clin Trl Info Mgt -DCP Enterprise System Knowledge Base (DESK)
-
批准号:10043978
-
项目类别:
-
资助金额:$63.35万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
DCP - COPTRG Support [National Surgical Adjuvant Breast and Bowel Project (NSABP)
-
批准号:10043963
-
项目类别:
-
资助金额:$4.27万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
DCP - Cancer Prevention Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia) BioRepository
-
批准号:10043976
-
项目类别:
-
资助金额:$2.3万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
TAS::75 0849::TAS INCREMENTAL FUNDING
-
批准号:10199838
-
项目类别:
-
资助金额:$17.05万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
Division of Cancer Tratment and DIagnosis- Operational Task Order
-
批准号:10199839
-
项目类别:
-
资助金额:$868.42万
-
财政年份:2019
-
负责人:LEONARD FREEDMAND
-
依托单位:
海外基金